The National Bowel Cancer Screening Program will reduce the burden of colorectal cancer, saving lives and money.1 The benefits of the program, however, rely on both public and private sectors to deliver colonoscopy, surgery and, if necessary, advanced cancer care. Public confidence in the whole program is likely to be affected by the affordability, ability and availability of these frontline services.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
The No Australians Dying of Bowel Cancer Initiative has received funding for this activity through approved disbursements from the Medical Research Future Fund (MRFF) Rapid Applied Research Translation Program. The Initiative acknowledges the MRFF and the Commonwealth Department of Health in supporting its aim to eradicate bowel cancer death in Australia. We thank Perry Fabian, Michael Schurgott, Stuart Keynes and James Trumble for anaesthetic support, and Clinpath for pathological services. We thank Carol Holden, Keith Willis, Michelle Coats and Kalindra Simpson for their administrative and nursing support to the program. We also thank the public colorectal surgical units that reviewed our patients who were diagnosed with cancer.
No relevant disclosures.